The FDA has approved a breakthrough blood test for detecting Alzheimer's disease, which could help diagnose the condition earlier and more accurately. This test measures specific biomarkers associated with Alzheimer's, making it a significant advancement in the fight against the disease and potentially transforming how patients are treated.